Cargando…
Selective Histocompatibility Leukocyte Antigen (Hla)-A2 Loss Caused by Aberrant Pre-mRNA Splicing in 624mel28 Melanoma Cells
Histocompatibility leukocyte antigen (HLA)-A2 is used as a restricting element to present several melanoma-associated antigen (MAA)-derived peptides to cytotoxic T lymphocytes (CTLs). HLA-A2 antigen is selectively lost in primary melanoma lesions and more frequently in metastases. Only scanty inform...
Autores principales: | Wang, Zhigang, Marincola, Francesco M., Rivoltini, Licia, Parmiani, Giorgio, Ferrone, Soldano |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2195569/ https://www.ncbi.nlm.nih.gov/pubmed/10432284 |
Ejemplares similares
-
Modulation of the Major Histocompatibility Complex Class II–Associated Peptide Repertoire by Human Histocompatibility Leukocyte Antigen (Hla)-Do
por: van Ham, Marieke, et al.
Publicado: (2000) -
T cell recognition of self-human histocompatibility leukocyte antigens (HLA)-DR peptides in context of syngeneic HLA-DR molecules
Publicado: (1992) -
Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs
Publicado: (1996) -
In Vivo Evidence for the Contribution of Human Histocompatibility Leukocyte Antigen (Hla)-Dq Molecules to the Development of Diabetes
por: Wen, Li, et al.
Publicado: (2000) -
Antiproliferative Effect of Rottlerin on Sk-Mel-28 Melanoma Cells
por: Daveri, Elena, et al.
Publicado: (2015)